Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - mumps virus, quantity: 5000 ccid50; measles virus, quantity: 1000 ccid50; rubella virus, quantity: 1000 ccid50 - injection, powder for - excipient ingredients: lactose; sorbitol; mannitol; threonine; serine; proline; glycine; alanine; valine; methionine; isoleucine; leucine; tyrosine; tryptophan; lysine hydrochloride; histidine; arginine; phenylalanine - priorix is indicated for active immunisation against measles, mumps and rubella from 12 months of age.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

professional complementary health formulas - all the following at 30x, 60x, 100x: bcg coxsackievirus cytomegalovirus epstein-barr virus haemophilus influenzae poliomyelitis roseola rubella vaccinotoxinum varicella - temporarily relieves fatigue, sore throat, minor aches and pains in the muscles or joints, occasional headache, chills, sweats, cough, nausea or vomiting, or abdominal discomfort.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Īrija - angļu - HPRA (Health Products Regulatory Authority)

glaxosmithkline consumer healthcare (ireland) limited - measles virus - schwarz strain live attenuated rubella virus (ra 27/3 strain) - solution for injection - 0.5 millilitre

Īrija - angļu - HPRA (Health Products Regulatory Authority)

glaxosmithkline consumer healthcare (ireland) limited - measles virus - schwarz strain live attenuated rubella virus (ra 27/3 strain) - solution for injection

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - measles virus; rubella virus; mumps virus; varicella vaccine - live -

Malta - angļu - Medicines Authority

glaxosmithkline biologicals s.a. rue de l'institut 89 b-1330 rixensart, belgium - pertactin, pertussis toxoid, poliovirus, inactivated, type, mahoney strain, mef, saukett strain, diphtheria toxoid, filamentous haemagglutinin, fha, tetanus toxoid - suspension for injection - diphtheria toxoid filamentous haemagglutinin (fha) 8 µg pertactin 2.5 µg pertussis toxoid 8 µg poliovirus (inactivated) type 1 (mahoney strain) 40 dagu poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu poliovirus (inactivated) type 3 (saukett strain) 32 dagu tetanus toxoid - vaccines

Malta - angļu - Medicines Authority

glaxosmithkline biologicals s.a. rue de l'institut 89 b-1330 rixensart, belgium - pertactin, pertussis toxoid, poliovirus, inactivated, type, mahoney strain, mef, saukett strain, diphtheria toxoid, filamentous haemagglutinin, fha, tetanus toxoid - suspension for injection in pre-filled syringe - pertactin 2.5 µg pertussis toxoid 8 µg poliovirus (inactivated) type 1 (mahoney strain) 40 dagu poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu poliovirus (inactivated) type 3 (saukett strain) 32 dagu diphtheria toxoid filamentous haemagglutinin (fha) 8 µg tetanus toxoid - vaccines

Filipīnas - angļu - FDA (Food And Drug Administration)

glaxosmithkline philippines, inc. - measles, mumps, rubella (mmr) vaccine (live, attenuated) [see formulation on reverse side] - powder for solution for injection (sc) - after reconstitution, each dose (0.5ml) contains: measles virus (schwarz strain), live attenuated nlt 10 3.0 ccid 50 mumps vir

Malaizija - angļu - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline pharmaceutical sdn. bhd. - live attenuated measles virus; live attenuated rubella virus; live attenuated mumps virus -

Malta - angļu - Medicines Authority

nm pharma limited 3/4, cantrija complex triq it-targa, il-maghtab naxxar nxr 6613 , malta - measles virus, schwarz strain, ccid, mumps vaccine, rit, rubella virus, wistar ra - powder and solvent for solution for injection in pre-filled syringe - measles virus - schwarz strain not less than 10 ccid50 mumps vaccine rit 4385 not less than 10 ccid50 rubella virus - wistar ra27/3 strain not less than 10 ccid50 - vaccines